TEVA

Teva Pharmaceutical Industries Ltd.

Price

$41.20

return (12m)

113.36%

p/e

67.98

p/bv

6.20

DIVIDEND YIELD

0.00%

TEVA price

Teva Pharmaceutical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment TEVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.86%

3 months

34.29%

1 year

113.36%

2 years

129.53%

5 years

306.31%

10 years

-1.19%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals TEVA

Valuation

P/E

67.98

Sector -3.10

Industry -3.10

P/BV

6.20

Sector 1.77

Industry 1.77

P/Revenue (PSR)

2.78

Sector 2.01

Industry 2.01

EV/EBITDA

-2,973.64

Sector -216.68

Industry -216.68

EV/EBIT

-217.30

Sector -46.14

Industry -46.14

P/EBITDA

19.00

Sector -21.54

Industry -21.54

P/EBIT

31.19

Sector -27.94

Industry -27.94

P/Total Assets

1.21

Sector 1.05

Industry 1.05

P/Net Current Assets

-2.62

Sector -9.24

Industry -9.24

P/Working Capital

-25.48

Sector -135.45

Industry -135.45

EPS

0.61

Sector -1.78

Industry -1.78

BVPS

6.66

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

52.46%

Sector 41.24%

Industry 41.24%

EBITDA Margin

-0.46%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

9.26%

Sector -35.37%

Industry -35.37%

Net Profit Margins

4.08%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

9.11%

Sector -57.47%

Industry -57.47%

ROA

1.77%

Sector -59.48%

Industry -59.48%

ROIC

1.68%

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.88

Sector 2.92

Industry 2.92

Net Debt / EBITDA

-444.05

Sector -21.38

Industry -21.38

Net Debt / EBIT

-32.45

Sector -8.29

Industry -8.29

Net Debt / Equity

1.09

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

1.56

Sector -0.84

Industry -0.84

Equity/Assets

0.19

Sector 0.46

Industry 0.46

Liabilities/Assets

0.81

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

1.75%

Sector -

Industry -

5Y Earnings CAGR

11.14%

Sector -

Industry -

Fundamentals TEVA

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Teva Pharmaceutical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$41.20

Fair Value

$9.56

Upside

-76.79%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TEVA Teva Pharmaceutical Industries Ltd.	$41.20	113.36%	0.00%	67.98	6.20	9.11%	4.08%
PFE Pfizer Inc.	$30.12	33.57%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$288.82	29.82%	2.40%	79.71	-84.84	-106.44%	9.81%
NVO Novo Nordisk A/S	$39.17	-26.22%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$148.12	79.82%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$168.31	2.07%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$61.32	48.74%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$79.65	-43.65%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$433.63	49.12%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$793.80	38.17%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$124.27	85.39%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$1,018.15	30.04%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$508.72	22.05%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$254.85	64.48%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$872.84	3.46%	0.00%	13.83	3.67	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$38.83	49.90%	0.00%	12.22	2.22	18.14%	18.88%
BIIB Biogen Inc.	$244.07	70.67%	0.00%	41.65	1.84	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TEVA - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	11/24/2017	12/12/2017	0.08500000
Dividends	08/25/2017	09/14/2017	0.08500000
Dividends	06/01/2017	06/22/2017	0.34000000
Dividends	02/28/2017	03/20/2017	0.34000000
Dividends	12/01/2016	12/20/2016	0.34000000
Dividends	08/18/2016	09/08/2016	0.34000000
Dividends	05/20/2016	06/07/2016	0.34000000
Dividends	02/25/2016	03/14/2016	0.34000000
Dividends	11/13/2015	12/03/2015	0.34000000
Dividends	08/18/2015	09/03/2015	0.34000000
Dividends	05/15/2015	06/04/2015	0.34000000
Dividends	02/17/2015	03/03/2015	0.34540000
Dividends	11/13/2014	12/02/2014	0.31720000
Dividends	08/19/2014	09/04/2014	0.35300000
Dividends	05/16/2014	06/02/2014	0.35030000
Dividends	02/20/2014	03/10/2014	0.34470000
Dividends	11/18/2013	12/03/2013	0.32650000
Dividends	08/16/2013	09/03/2013	0.32200000
Dividends	05/16/2013	06/03/2013	0.31560000
Dividends	02/19/2013	03/07/2013	0.31400000
Dividends	11/13/2012	12/03/2012	0.25520000
Dividends	08/13/2012	09/04/2012	0.24800000
Dividends	05/17/2012	06/04/2012	0.26140000
Dividends	02/23/2012	03/13/2012	0.26300000
Dividends	11/10/2011	12/07/2011	0.21490000
Dividends	08/01/2011	08/25/2011	0.23100000
Dividends	05/19/2011	06/07/2011	0.22980000
Dividends	02/10/2011	03/07/2011	0.21680000
Dividends	11/08/2010	12/06/2010	0.19010000
Dividends	08/02/2010	08/26/2010	0.18350000
Dividends	05/10/2010	06/04/2010	0.17930000
Dividends	02/19/2010	03/17/2010	0.18430000
Dividends	11/06/2009	12/04/2009	0.15680000
Dividends	08/03/2009	08/27/2009	0.15600000
Dividends	05/08/2009	06/03/2009	0.15030000
Dividends	02/23/2009	03/19/2009	0.14000000
Dividends	11/10/2008	12/05/2008	0.11150000
Dividends	08/01/2008	08/27/2008	0.12480000
Dividends	05/13/2008	06/05/2008	0.13480000
Dividends	02/18/2008	03/13/2008	0.12180000
Dividends	11/02/2007	11/28/2007	0.10060000
Dividends	08/10/2007	09/06/2007	0.09540000
Dividends	05/10/2007	06/05/2007	0.09920000
Dividends	02/19/2007	03/15/2007	0.09360000
Dividends	11/10/2006	12/06/2006	0.07820000
Dividends	08/11/2006	09/08/2006	0.07660000
Dividends	05/12/2006	06/07/2006	0.07450000
Dividends	03/06/2006	03/30/2006	0.07230000
Dividends	11/11/2005	12/07/2005	0.06330000
Dividends	08/11/2005	09/07/2005	0.06620000
Dividends	05/05/2005	06/01/2005	0.06810000
Dividends	02/18/2005	03/17/2005	0.06860000
Dividends	11/10/2004	12/06/2004	0.05090000
Dividends	08/09/2004	09/07/2004	0.04920000
Dividends	05/10/2004	06/07/2004	0.04860000
Dividends	02/23/2004	03/22/2004	0.04940000
Dividends	11/13/2003	12/12/2003	0.03670000
Dividends	08/08/2003	09/08/2003	0.03680000
Dividends	05/08/2003	06/06/2003	0.03580000
Dividends	02/24/2003	03/24/2003	0.03380000
Dividends	11/08/2002	12/06/2002	0.02280000
Dividends	08/19/2002	09/16/2002	0.02280000
Dividends	05/20/2002	06/17/2002	0.02160000
Dividends	02/18/2002	03/18/2002	0.02300000
Dividends	11/16/2001	12/17/2001	0.01580000
Dividends	08/17/2001	09/17/2001	0.01580000
Dividends	05/17/2001	06/15/2001	0.01620000
Dividends	03/08/2001	04/06/2001	0.01590000
Dividends	11/16/2000	12/15/2000	0.01360000
Dividends	08/24/2000	09/21/2000	0.01380000
Dividends	05/19/2000	06/19/2000	0.01350000
Dividends	02/18/2000	03/27/2000	0.16800000
Dividends	11/04/1999	11/30/1999	0.008800
Dividends	08/18/1999	09/13/1999	0.008800
Dividends	05/21/1999	06/15/1999	0.009000
Dividends	03/08/1999	03/30/1999	0.009100
Dividends	11/20/1998	12/11/1998	0.008800
Dividends	08/21/1998	09/11/1998	0.009700
Dividends	05/22/1998	06/22/1998	0.01020000
Dividends	03/12/1998	03/31/1998	0.008100
Dividends	11/20/1997	12/09/1997	0.008300
Dividends	08/25/1997	09/11/1997	0.008300
Dividends	05/26/1997	06/12/1997	0.008600
Dividends	03/07/1997	03/26/1997	0.008700
Dividends	11/22/1996	12/09/1996	0.005800
Dividends	08/26/1996	09/12/1996	0.006200
Dividends	05/24/1996	06/12/1996	0.006000
Dividends	03/07/1996	03/26/1996	0.006300
Dividends	11/20/1995	12/07/1995	0.006100
Dividends	08/14/1995	08/30/1995	0.006100
Dividends	05/19/1995	06/05/1995	0.008400
Dividends	03/09/1995	04/04/1995	0.006400
Dividends	11/17/1994	12/13/1994	0.006400
Dividends	08/11/1994	09/12/1994	0.006400
Dividends	05/20/1994	06/21/1994	0.02560000
Dividends	03/10/1994	04/05/1994	0.006600
Dividends	11/18/1993	01/03/1994	0.005000
Dividends	08/19/1993	09/14/1993	0.005500
Dividends	06/02/1993	06/24/1993	0.003800
Dividends	11/19/1992	12/21/1992	0.002500
Dividends	08/20/1992	09/21/1992	0.002600
Dividends	05/22/1992	06/22/1992	0.002600
Dividends	03/05/1992	03/31/1992	0.003100
Dividends	11/22/1991	12/19/1991	0.002300
Dividends	08/23/1991	09/19/1991	0.003000
Dividends	05/23/1991	06/20/1991	0.002500
Dividends	03/07/1991	03/28/1991	0.002800
Dividends	11/23/1990	12/20/1990	0.002313
Dividends	08/21/1990	09/17/1990	0.002700
Dividends	05/24/1990	06/21/1990	0.002800
Dividends	03/12/1990	04/05/1990	0.002900

ABOUT Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd.

Average Investor10 user rating

4.0 (9 people)

United States

82 years

Founded: 1944

1990

Time since IPO - 36 years

40.216

Employees

Teva Pharmaceutical Industries Ltd. (United States) is listed on the NYSE and has a market capitalization of $48.06 billion, with shareholders equity totaling $7.76 billion.

The company employs approximately 40.216 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Teva Pharmaceutical Industries Ltd. reported $17.32 billion in revenue, generating net income of $707.00 million.

Key financial metrics include a P/E ratio of 67.98, a price-to-book (P/B) ratio of 6.20, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TEVA.

Market cap

$48.06 billion

Net worth

$7.76 billion

$7,757,000,000.00

Assets

$39.86 billion

$39,857,000,000.00

Total Shares Outstanding

1.17 billion

1,165,000,000

Average Daily Trading Volume

$5.65 million

$5,646,316.00

Sector

Health Care

Industry

Biotechnology

TEVA

revenue by Business Segment Teva Pharmaceutical

Revenue by Region Teva Pharmaceutical

TEVA revenue and profits

Financial Results TEVA

DRAG THE FRAME TO SEE MORE DATA

TEVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,018.15 29,74% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$254.85 63,58% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$288.82 28,43% (12M)

P/E

79.71

2.40%

ROE

-106.44%

P/BV

-84.84

MRK - Merck & Co.

$148.12 76,63% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$168.31 2,87% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$30.12 32,60% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$61.32 48,87% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,018.15 29,74% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$254.85 63,58% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$288.82 28,43% (12 M)

P/L

79.71

2.40%

ROE

-106.44%

P/VP

-84.84

MRK - Merck & Co.

$148.12 76,63% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$168.31 2,87% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$30.12 32,60% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$61.32 48,87% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of Teva Pharmaceutical (TEVA) today?

The current price of Teva Pharmaceutical (TEVA) is $41.20. The stock began the year trading around $31.21 and is currently priced at $41.20. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Teva Pharmaceutical (TEVA) pay dividends?

Teva Pharmaceutical (TEVA) did not pay dividends over the past year.

Is Teva Pharmaceutical (TEVA) a good investment?

Teva Pharmaceutical (TEVA) is currently trading at $41.20 with a P/E ratio of 67.98. This represents a 1,059% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 113.36%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Teva Pharmaceutical (TEVA) stock?

You can buy Teva Pharmaceutical (TEVA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol TEVA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Teva Pharmaceutical (TEVA) yield today?

Over the past month, Teva Pharmaceutical (TEVA) has returned 3.86% — 113.36% over the past year, and 306.31% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Teva Pharmaceutical (TEVA) today at the current price of $41.20 your total investment would be $4,120.00.

Based on historical performance, the investment would have grown to approximately:

$8,790.43 after 1 year
$16,739.97 after 5 years
$4,070.97 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TEVA

Teva Pharmaceutical Industries Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TEVA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING TEVA WITH OTHER STOCK

type

Ex - Dividend Date

payment date

value

ABOUT Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd.

United States

82 years

1990

40.216

PROFIT X PRICE TEVA

Financial Results TEVA

TEVA cash flow

Asset, Revenue and Profit Growth - TEVA

TEVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions